RENOVORX, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding
RENOVORX, INC. (RNXT) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding of $64.31 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding · last filed 2026-08-13
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding $64.31M.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding $69.14M.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding $59.80M.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding $59.89M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding |
|---|---|
| 2026-06-30 | $64.31M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $69.14M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $59.80M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $59.89M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $59.96M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $59.99M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $59.30M 10-K · filed 2026-03-30 |
| 2024-09-30 | $58.63M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $58.63M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $42.97M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $36.35M 10-K · filed 2025-04-01 |
| 2023-09-30 | $36.35M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $36.35M 10-Q · filed 2023-08-16 |
| 2023-03-31 | $30.10M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $30.10M 10-K · filed 2024-04-01 |
| 2022-09-30 | $30.10M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $30.10M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $30.10M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $30.10M 10-K · filed 2023-03-31 |
| 2021-09-30 | $27.11M 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |